Quantum-Si and HighCape Capital Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination

Special meeting of HighCape stockholders scheduled for June 9, 2021 NEW YORK and GUILFORD, Conn., May 17, 2021 (GLOBE NEWSWIRE) — Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, and HighCape Capital Acquisition Corp. (“HighCape”), a healthcare-focused special purpose acquisition company (SPAC), today announced that the Securities and Exchange Commission (“SEC”) has declared the Registration […]

Quantum-Si Strengthens Board of Directors with Two Key Appointments

GUILFORD, Conn.–(BUSINESS WIRE)–Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Marijn Dekkers, Ph.D. and Ruth Fattori to its Board of Directors. Both Dr. Dekkers and Ms. Fattori have agreed to continue to serve on the Board of Directors of the combined company subsequent to the closing of the previously […]

Quantum-Si Appoints Dr. Michael Mina as Chief Medical Advisor

GUILFORD, Conn.–(BUSINESS WIRE)–Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Michael Mina, M.D., Ph.D., Assistant Professor of Epidemiology, Immunology, Infectious Diseases and Pathology at the Harvard T.H. Chan School of Public Health and Harvard Medical School, as Chief Medical Advisor for the company. “As we create the next generation […]

Quantum-Si Announces Appointment of Claudia Napal Drayton as Chief Financial Officer

GUILFORD, Conn.–(BUSINESS WIRE)–Quantum-Si Incorporated, a pioneer in next-generation semiconductor chip-based proteomics, announced today the appointment of Claudia Napal Drayton as Chief Financial Officer. “Claudia joins Quantum-Si at a period of growth in anticipation of our planned merger with HighCape Capital Acquisition Corp. and oversubscribed $425 million PIPE financing to pioneer an end-to-end proteomics solution,” said […]

Quantum-Si, a Pioneer in Semiconductor Chip-Based Proteomics, to Combine with HighCape Capital Acquisition Corp.

The transaction will merge Quantum-Si’s revolutionary, end-to-end proteomics solution, and HighCape Capital Acquisition Corp., a healthcare-focused SPAC sponsored by leading healthcare growth equity investment firm HighCape Capital LP.   The transaction is further supported by an oversubscribed $425 million PIPE with participation from leading institutional investors, including Foresite Capital Management, LLC, Eldridge, accounts advised by […]